Northern Trust Corp trimmed its position in Walgreens Boots Alliance (NASDAQ:WBA) by 2.6% in the first quarter, HoldingsChannel reports. The firm owned 10,893,924 shares of the pharmacy operator’s stock after selling 290,106 shares during the quarter. Northern Trust Corp’s holdings in Walgreens Boots Alliance were worth $713,225,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of WBA. Alpha Omega Wealth Management LLC grew its stake in Walgreens Boots Alliance by 100.0% in the first quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 800 shares in the last quarter. Financial Advocates Investment Management acquired a new position in Walgreens Boots Alliance in the fourth quarter worth about $125,000. Fieldpoint Private Securities LLC grew its stake in Walgreens Boots Alliance by 428.6% in the fourth quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock worth $134,000 after purchasing an additional 1,500 shares in the last quarter. QCI Asset Management Inc. NY grew its stake in Walgreens Boots Alliance by 95.9% in the first quarter. QCI Asset Management Inc. NY now owns 2,155 shares of the pharmacy operator’s stock worth $141,000 after purchasing an additional 1,055 shares in the last quarter. Finally, Reilly Financial Advisors LLC grew its stake in Walgreens Boots Alliance by 69.1% in the first quarter. Reilly Financial Advisors LLC now owns 2,242 shares of the pharmacy operator’s stock worth $147,000 after purchasing an additional 916 shares in the last quarter. Institutional investors and hedge funds own 60.57% of the company’s stock.
Shares of NASDAQ WBA opened at $64.34 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. The company has a market cap of $63.80 billion, a PE ratio of 11.39, a price-to-earnings-growth ratio of 1.04 and a beta of 1.15. Walgreens Boots Alliance has a 12-month low of $61.56 and a 12-month high of $83.89.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.55 by $0.18. The business had revenue of $33.02 billion during the quarter, compared to the consensus estimate of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The business’s revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.36 earnings per share. analysts predict that Walgreens Boots Alliance will post 5.92 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.49%. Walgreens Boots Alliance’s dividend payout ratio is presently 31.37%.
A number of research firms recently commented on WBA. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, May 8th. Barclays began coverage on Walgreens Boots Alliance in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a research note on Thursday, March 22nd. Finally, Royal Bank of Canada set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Friday, February 16th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $83.20.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total transaction of $179,372.16. Following the completion of the transaction, the director now directly owns 13,679 shares in the company, valued at $896,795.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.